These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 8964450

  • 1. [Significance of PCNA proliferating fraction for prognosis of ovarian carcinoma].
    Schönborn I, Minguillon C, Reles A, Bartel U, Lichtenegger W.
    Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):357-64. PubMed ID: 8964450
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc.
    Kuhn W, Schmalfeldt B, Reuning U, Pache L, Berger U, Ulm K, Harbeck N, Späthe K, Dettmar P, Höfler H, Jänicke F, Schmitt M, Graeff H.
    Br J Cancer; 1999 Apr; 79(11-12):1746-51. PubMed ID: 10206287
    [Abstract] [Full Text] [Related]

  • 3. EGF-R and PCNA expression in ovarian carcinomas--correlation with classic prognostic factors.
    Minguillon C, Schönborn I, Reles A, Bartel U, Lichtenegger W.
    Gen Diagn Pathol; 1996 Mar; 141(3-4):197-201. PubMed ID: 8705783
    [Abstract] [Full Text] [Related]

  • 4. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A, Masetti R, Breccia C, Coppola R, Magistrelli P, Nuzzo G, Maggiano N, Picciocchi A.
    Hepatogastroenterology; 1999 Mar; 46(26):1187-91. PubMed ID: 10370689
    [Abstract] [Full Text] [Related]

  • 5. [Proliferating cell nuclear antigen (PCNA) in ovarian carcinoma and its relation to lymph node metastasis and prognosis].
    Wu X, Zhang Z, Cai S.
    Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):68-70. PubMed ID: 10921065
    [Abstract] [Full Text] [Related]

  • 6. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M, Rudlowski C, Biesterfeld S, Rath W, Schröder W.
    Zentralbl Gynakol; 2000 Jan; 122(7):361-7. PubMed ID: 10951706
    [Abstract] [Full Text] [Related]

  • 7. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
    Li JD, Li MD, Li YF, Huang X, Liu JH, Liu FY, Zhang CQ.
    Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?
    Plastiras D, Moutzouris G, Barbatis C, Presvelos V, Petrakos M, Theodorou C.
    Eur J Surg Oncol; 1999 Feb; 25(1):61-5. PubMed ID: 10188857
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
    Kurokawa H, Yamashita Y, Takeda S, Miura K, Murata T, Kajiyama M.
    Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
    [Abstract] [Full Text] [Related]

  • 12. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
    Volm M, Koomägi R.
    Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513
    [Abstract] [Full Text] [Related]

  • 13. Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients.
    Myoung H, Kim MJ, Lee JH, Ok YJ, Paeng JY, Yun PY.
    Int J Oral Maxillofac Surg; 2006 Nov; 35(11):1005-10. PubMed ID: 17018251
    [Abstract] [Full Text] [Related]

  • 14. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
    Engels K, du Bois A, Harter P, Fisseler-Eckhoff A, Kommoss F, Stauber R, Kaufmann M, Nekljudova V, Loibl S.
    J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
    [Abstract] [Full Text] [Related]

  • 15. PCNA and laminin as prognostic factors in primary Fallopian tube carcinoma.
    Hałoń A, Rabczyński J.
    Folia Morphol (Warsz); 2003 Nov; 62(4):475-8. PubMed ID: 14655145
    [Abstract] [Full Text] [Related]

  • 16. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
    Lengyel E, Schmalfeldt B, Konik E, Späthe K, Härting K, Fenn A, Berger U, Fridman R, Schmitt M, Prechtel D, Kuhn W.
    Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
    [Abstract] [Full Text] [Related]

  • 17. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
    Salvesen HB, Iversen OE, Akslen LA.
    Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
    [Abstract] [Full Text] [Related]

  • 18. C-erbB-2 and PCNA as prognostic indicators of long-term survival in breast cancer.
    Kato T, Kameoka S, Kimura T, Nishikawa T, Kobayashi M.
    Anticancer Res; 2002 Nov; 22(2B):1097-103. PubMed ID: 12168907
    [Abstract] [Full Text] [Related]

  • 19. [Clinical course of ovarian cancer in relation to morphologic prognostic factors and cell kinetic parameters].
    Kühn W, Feichter GE, Hanke J, Rummel HH, Kaufmann M, Schmid H.
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):446-51. PubMed ID: 3623047
    [Abstract] [Full Text] [Related]

  • 20. [Value of the proliferation status (PCNA) and p53 immunohistochemistry as a prognostic factor for the clinical course of superficial cancer of the urinary bladder].
    Kuczyk MA, Serth J, Bokemeyer C, Hervatin C, Oelke M, Oelert F, Höfner K, Jonas U.
    Urologe A; 1995 Mar; 34(2):146-52. PubMed ID: 7754587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.